Physiomics PLC
LSE:PYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Workspace Group PLC
LSE:WKP
|
UK |
|
Dominari Holdings Inc
NASDAQ:DOMH
|
US |
|
T
|
Tokatsu Holdings Co Ltd
TSE:2754
|
JP |
|
Ushio Inc
TSE:6925
|
JP |
|
Matterport Inc
NASDAQ:MTTR
|
US |
|
Kamat Hotels (India) Ltd
NSE:KAMATHOTEL
|
IN |
|
Scigineer Inc
TSE:6031
|
JP |
|
Tower Ltd
NZX:TWR
|
NZ |
|
S
|
Shanxi Guoxin Energy Corp Ltd
SSE:600617
|
CN |
|
P
|
Prince Pipes and Fittings Ltd
BSE:542907
|
IN |
|
Kloeckner & Co SE
XETRA:KCO
|
DE |
|
Universal Health Realty Income Trust
NYSE:UHT
|
US |
|
X
|
xReality Group Ltd
ASX:XRG
|
AU |
|
Suzhou TZTEK Technology Co Ltd
SSE:688003
|
CN |
|
R
|
Reeder Teknoloji Sanayi ve Ticaret AS
IST:REEDR.E
|
TR |
|
China Railway Construction Corp Ltd
SSE:601186
|
CN |
|
Shenzhen Rapoo Technology Co Ltd
SZSE:002577
|
CN |
|
SKAN Group AG
SIX:SKAN
|
CH |
|
M
|
MKH Oil Palm East Kalimantan Bhd
KLSE:MKHOP
|
MY |
|
G
|
Genting Singapore Ltd
OTC:GIGNY
|
SG |
|
K
|
KLASSIK RADIO AG
SWB:KA8
|
DE |
|
Usak Seramik Sanayi AS
IST:USAK.E
|
TR |
Physiomics PLC
Total Current Assets
Physiomics PLC
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Physiomics PLC
LSE:PYC
|
Total Current Assets
£545k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
0%
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Total Current Assets
£420m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Total Current Assets
£29.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
G
|
Genedrive PLC
LSE:GDR
|
Total Current Assets
£1.6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-12%
|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Total Current Assets
£1.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Total Current Assets
£42.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
32%
|
|
Physiomics PLC
Glance View
Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. The company is headquartered in Oxford, Oxfordshire and currently employs 7 full-time employees. The company went IPO on 2004-12-20. The firm offer Virtual Tumour technology and other tools to predict the effects of cancer treatments. The Company’s Virtual Tumour software platform is used to simulate the effects of anti-cancer agents on pre-clinical and human tumors. The company is used by companies ranging from startup biotech to global large-cap pharmaceuticals. The firm provides a range of Pharmacokinetic/Pharmacodynamics (PK/PD) services, usually in support of smaller companies where this function is outsourced. The Company’s services include oncology specialists, mechanistic modelling, PK/PD, quantitative systems pharmacology and mathematical modelling.
See Also
What is Physiomics PLC's Total Current Assets?
Total Current Assets
545k
GBP
Based on the financial report for Dec 31, 2025, Physiomics PLC's Total Current Assets amounts to 545k GBP.
What is Physiomics PLC's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
0%
Over the last year, the Total Current Assets growth was 8%. The average annual Total Current Assets growth rates for Physiomics PLC have been -17% over the past three years , -17% over the past five years .
